Alembic Pharmaceuticals LimitedNSE: APLLTD

Alembic Pharmaceuticals Limited Press Release Nov 11 2024

· Issued by Alembic Pharmaceuticals Limited via NSE India

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/alembic-pharmaceuticals-limited-press-release-nov-11-2024

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 11, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Diltiazem HydrochlorideExtended-Release Capsules USP, 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg".

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases